This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology ... instrument for next-generation sequencing (NGS), Aviti, which is a competitor to Illumina technology, like its ...

Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

China has banned the import of Illumina’s next-generation sequencing ... and use a technology known as sequencing by synthesis (SBS) to enhance DNA short-read sequence generation.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Illumina, Inc., a global leader in next-generation sequencing and array-based technologies ... It focus on innovation has established us as a global leader in DNA sequencing and array-based ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

“We also increased several of our other existing positions including the next-generation sequencing platform Illumina, Inc. (NASDAQ:ILMN) – as we believe the company remains well positioned to ...